Physician profile
Thomas L Bradbury
NPI 1720019698
$1,921,672.92
in general payments reported to CMS, 2019-2025
20 companies · $566K in 2025
The $566K reported for 2025 was more than what 97% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $40K · 2021: $164K · 2022: $281K · 2023: $362K · 2024: $484K · 2025: $566K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Education: $7,500 · Food and Beverage: $4,648 · Long Term Medical Supply Or Device Loan: $2,459 · Travel and Lodging: $702 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,396,635.69 |
| Education | $7,500.00 |
| Food and Beverage | $4,647.60 |
| Long Term Medical Supply Or Device Loan | $2,459.02 |
| Travel and Lodging | $702.30 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,874,062.20 | 2019-2025 | Avenir, Mymobility Platform, Persona |
| Total Joint Orthopedics, INC. | $32,390.95 | 2019-2024 | |
| Think Surgical, INC. | $12,486.39 | 2019-2024 | |
| Smith+Nephew, INC. | $738.41 | 2020-2025 | Real Intelligence, Journey II |
| Medacta USA, INC. | $426.24 | 2022-2024 | Gmk Revision, Amistem |
| Microport Orthopedics INC | $357.44 | 2022-2023 | Mpo Medial Pivot Knee |
| Osteoremedies, LLC | $216.57 | 2025 | Osteoboost Select 5cc, Biowash Surgical Irrigation, Biobrush |
| Stryker Corporation | $192.69 | 2019-2025 | Mako |
| Abbott Laboratories | $164.31 | 2024 | Proclaim |
| Becton, Dickinson and Company | $157.82 | 2024 | Arista Ah Flexitip |
| Arthrosurface Incorporated | $138.00 | 2020 | |
| Curonix LLC | $90.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $65.77 | 2024-2025 | Zilretta, Iovera, Exparel |
| Medical Device Business Services, INC. | $55.00 | 2022 | |
| Ermi LLC | $37.13 | 2022-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $29.26 | 2025 | |
| Ferring Pharmaceuticals INC. | $24.01 | 2024 | Euflexxa |
| Convatec INC. | $23.60 | 2025 | |
| Supreme Orthopedic Systems, LLC | $16.32 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bradbury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.